Phase I clinical trial - Phases précoces tumeurs solides

INCB 86550-102
Phases précoces tumeurs solides
Ouvert depuis le: 01.24.2022
Site: Paris
Public cible
A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors
Description de l'essai

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, pharmacodynamics, and early clinical activity of INCB086550 in participants with advanced solid tumors who have failed prior treatments